Results 51 to 60 of about 13,036 (233)

Pyoderma Gangrenosum After Insertion of a Hemodialysis Catheter: Koebner Phenomenon, Systemic Inflammatory Response Syndrome, and a Delay in Diagnosis

Canadian Journal of Kidney Health and Disease, 2022
Rationale: Pyoderma gangrenosum is a rare neutrophilic dermatosis. Misdiagnosis of pyoderma gangrenosum as an infection is not uncommon. Pyoderma gangrenosum can be associated with Koebner phenomenon and rarely results in systemic inflammatory response ...
Majed M. Alosaimi, Fatemah Sebzali, Ali Iqbal, Christian G. Rabbat, Catherine M. Clase   +4 more
doaj   +1 more source

Cutaneous Manifestations in Inflammatory Bowel Diseases [PDF]

, 2015
Inflammatory bowel diseases have a high frequency in Europe. They are chronic disorders that evolve with relapses and remissions. Clinical features include the signs of underlying inflammatory bowel disease and also signs of extraintestinal ...
Benea, Vasile, Costescu, Monica, Georgescu, Simona Roxana, Mitran, Cristina Iulia, Mitran, Madalina Irina, Sarbu, Maria Isabela, Tampa, Mircea   +6 more
core   +3 more sources

Surgical Reconstruction in Pyoderma Gangrenosum, a Retrospective Study of Five Patients

JEADV Clinical Practice, EarlyView.
ABSTRACT Pyoderma Gangrenosum (PG) is a neutrophilic dermatosis characterized by chronic painful ulcerations most commonly on the lower extremities. Current treatment options for PG are largely nonsurgical and include the use of systemic and topical immunomodulators and wound care.
Max E. Oscherwitz, Alysia B. Kohrs, Jacob C. Maus, Matthew L. Hrin, Maria C. Mariencheck, Joseph L. Jorizzo, Kyle E. Robinson, Joseph A. Molnar, Lindsay C. Strowd   +8 more
wiley   +1 more source

Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Epidermal necrolysis (EN), including Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous drug reactions with high morbidity. However, the quality of life (QoL) impact during acute hospitalization is not well understood.
Jacob McFeeters, Allison Yan, Cole Veliky, Matthew Gallardo, Kelsey Nusbaum, Rachel Kirven, Kristopher Fisher, Abraham Korman, Hyoshin Kim, Benjamin H. Kaffenberger   +9 more
wiley   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Pyoderma gangrenosum post open radical prostatectomy – A complication every urologist should consider and recognise

Urology Case Reports
Post-operative pyoderma gangrenosum is a rare neutrophilic dermatosis which forms within skin wounds following surgery. This condition is not well recognised, can be difficult to diagnose and often mimics necrotising fasciitis.
Samuel MacDiarmid, Harriet Baxter, Jordan Mann, Christophe Chemasle   +3 more
doaj   +1 more source

Pyoderma gangrenosum – a review [PDF]

, 2007
Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic dermatosis. Clinically it starts with sterile pustules that rapidly progress and turn into painful ulcers of variable depth and size with undermined violaceous borders.
Uwe Wollina, LA Brunsting, P Van den Driesch, AN Crowson, FC Powell, FC Powell, JA Graham, DC Dick, FC Powell, HM Van Hale, SM Schwaegerle, H Yeo, E Miserocchi, T Langeland, S Krüger, ZP Mijuskovic, I Marie, RC Hayes, S Van Poucke, B Horner, RK Fulbright, ML Bennett, CN Bernstein, S Ozdil, S Ozdil, U Wollina, L Török, CA Charles, NM Lindor, RH Weenig, CA Wise, K Gungor, LE White, R Sagara, WPD Su, S Shaya, Y Adachi, HJ Park, RH Weenig, CCY Oh, RB Johnson, WL Matis, B O'Donnell, M Zumdick, D Vidal, JH Prystowsky, JL Arbiser, V Peuckmann, GJ Kontochristopoulos, C Schmidt, U Wollina, NH Daniels, MR Lee, K Budde, G Girolomoni, D Mimouni, MS Sapienza, I Kaufman, DW Hommes, DB Roy, DC Baumgart, E Fujimoto, S Mori, MC Lazarous, U Wollina, H Yeo, M Khurrum Baig, SM Rozen, M Limova, G De Imus, J Hafner, FC Powell   +71 more
core   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, Kyle Cullingham   +4 more
wiley   +1 more source

Sweet syndrome with pulmonary involvement in a patient with myelodysplastic syndrome [PDF]

, 2020
We report a patient with Sweet syndrome involving the pulmonary system in the context of myelodysplastic syndrome. Although Sweet syndrome may involve a variety of organ systems, the pulmonary system is rarely affected and can result in poor clinical ...
Bordelon, Jenna, Ho, Jonhan, James, Alaina, Karunamurthy, Arivarasan, Kazlouskaya, Viktoryia, Khosravi, Hasan, Mizes, Alicia, Patton, Timothy   +7 more
core  

Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported [PDF]

, 2016
Extra-intestinal manifestations are well recognized in inflammatory bowel disease (IBD). To what extent the commonly recognized extra-intestinal manifestations seen in IBD patients are attributable to IBD is, however, not clear due to the limited number ...
B Hammer, C Ciccacci, CN Bernstein, CN Bernstein, CN Bernstein, DK Christodoulou, E Herrett, G Gupta, H Jick, JC Alonso Farto, JD Lewis, MJ Grainge, Sinéad M. Langan, SM Langan, SR Vavricka, Thomas P. C. Chu, Timothy R. Card   +16 more
core   +3 more sources